We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on trade sanctions, arms embargoes and trade restrictions, including trade controls, transit controls and restrictions on terrorist organisations.
We have strengthened the safe use of isotretinoin through the introduction of additional oversight of the initiation of isotretinoin in patients under 18 years and through improved assessment and monitoring of mental health and sexual function issues. We ask healthcare...
Pharmacovigilance system requirements
Residential Property First Tier Tribunal Decision of Judge Anthea Rawlence on Monday 5th July 2021.
Northern Region Judge C. Green and Members Mr K. Kasambara sitting on 17 May 2019
FCDO travel advice for Chad. Includes safety and security, insurance, entry requirements and legal differences.
Guidance on the ventilation of indoor spaces to reduce the spread of respiratory infections, including coronavirus (COVID-19).
Closed: Call for proposals by 2 February 2024 to provide analysis of development finance investments and strategies, including their influence on similar financial transactions and impact on global financial markets.
Residential Property Tribunal Decision of J A Naylor MRICS FIRPM dated 27 February 2023
This report has considered the harms and control of 2-methyl-AP-237 and other closely related acyl piperazine opioids.
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).